Skip to main content
SleepCited

타우린 관련 불면증

B

Taurine은 뇌에서 GABA-A 및 glycine 수용체를 조절하는 억제성 아미노산입니다. 전임상 연구에서 진정 및 항불안 효과가 입증되었습니다. 제한된 인체 데이터에 따르면 taurine이 특히 마그네슘이나 GABA와 병용할 때 수면의 질을 지원할 수 있습니다. 더 많은 임상 시험이 필요합니다.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'ingredient\u003Dtaurine\u0026condition\u003Dinsomnia'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

결론

Taurine은 뇌에서 GABA-A 및 glycine 수용체를 조절하는 억제성 아미노산입니다. 전임상 연구에서 진정 및 항불안 효과가 입증되었습니다. 제한된 인체 데이터에 따르면 taurine이 특히 마그네슘이나 GABA와 병용할 때 수면의 질을 지원할 수 있습니다. 더 많은 임상 시험이 필요합니다.

Key Study Findings

basic science
Lactobacillus reuteri E9 Regulates Sleep Disorders Through Its Metabolite GABA.
Dose: Lactobacillus reuteri E9 (dose not specified) vs: Placebo 효과: None < 0.05
Controlled Clinical Trial n=32 12 weeks Open-label
Efficacy and associated neurotransmitters of digital cognitive behavior therapy for atopic dermatitis: A comparative effectiveness …
Dose: None vs: Standard care alone Outcome: Itch and insomnia improvement in atopic dermatitis 효과: None 0.0449 (itch), 0.0089 (insomni

대상 집단: Patients with atopic dermatitis and mild-moderate negative emotions

Review
Commonly encountered symptoms and their management in patients with cirrhosis.
Dose: None vs: None Outcome: Pain outcomes 효과: None None

대상 집단: Insomnia patients

Other
Energy drinks in Tamale: Understanding youth perceptions, consumption patterns, and related factors.
Dose: None vs: None Outcome: None 효과: None p < .05

대상 집단: Insomnia patients

Observational Study
[Energy drink consumption patterns and its adverse effects on adolescent health.].
Dose: None vs: None Outcome: Energy drink consumption and adverse effects 효과: None None

대상 집단: Adolescents

Other
[Establishment of rat heart-kidney insomnia model consistent with traditional Chinese medicine syndrome and its serum …
Dose: None vs: None Outcome: rat model of cardiorenal insomnia from in vitro … 효과: None None

대상 집단: None

Key Statistics

11

연구

32

참여자

Mixed

B

등급

Referenced Papers

British journal of … 2014 111 인용
Alcohol and alcoholism … 2011 40 인용

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

sleep:
500-2,000 mg, 1 hour before bed

상한량: 3,000 mg/day considered safe in clinical studies

연구에서 사용된 용량

용량 기간 효과 N
Lactobacillus reuteri E9 (dose not specified) -- Positive --
None 12 weeks Positive 32
None -- Neutral --
None -- Neutral --
None -- Mixed --
None -- Mixed --
None -- Positive --
None -- Positive --

권장 복용 시간: 1 hour before bed

Safety & Side Effects

보고된 부작용

  • Generally well tolerated
  • Mild GI discomfort at high doses
  • Drowsiness (desired for sleep use)

알려진 상호작용

  • Lithium — taurine may alter lithium excretion
  • Antihypertensives — may have additive blood pressure lowering effects
  • CNS depressants — potential additive sedative effects

일일 최대 섭취 허용량: 3,000 mg/day considered safe in clinical studies

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does 타우린 help with 불면증?
Based on 11 studies with 32 participants, there is moderate evidence from clinical studies that 타우린 may support 불면증 management. Our evidence grade is B (Good Evidence).
How much 타우린 should I take for 불면증?
Studies have used various dosages. A commonly studied range is 500-2,000 mg, 1 hour before bed. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of 타우린?
Reported side effects may include Generally well tolerated, Mild GI discomfort at high doses, Drowsiness (desired for sleep use). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for 타우린 and 불면증?
We rate the evidence as Grade B (Good Evidence). This rating is based on 11 peer-reviewed studies with 32 total participants. The overall direction of effect is mixed.

Related Evidence

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.